Themis Medicare Limited (NSE:THEMISMED)

Market Cap	13.75B
Revenue (ttm)	4.32B
Net Income (ttm)	461.41M
Shares Out	n/a
EPS (ttm)	5.00
PE Ratio	29.80
Forward PE	n/a
Dividend	0.50 (0.33%)
Ex-Dividend Date	Jul 12, 2024

Volume	837,840
Average Volume	86,845
Open	153.40
Previous Close	151.10
Day's Range	151.50 - 176.00
52-Week Range	115.00 - 317.00
Beta	-0.07
RSI	63.30
Earnings Date	May 30, 2025

About Themis Medicare

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Th...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1952
• Employees: 1,509
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: THEMISMED

Financial Performance

In 2023, Themis Medicare's revenue was 3.82 billion, an increase of 7.74% compared to the previous year's 3.54 billion. Earnings were 435.24 million, a decrease of -23.51%.